Theweek
Which Paragon spinout is going public through a reverse merger again?
BioPharma Dive reported on October 13, 2026 that another Paragon spinout is using a reverse merger to go public. The excerpt doesn’t name the company or disclose terms, but it emphasizes Paragon and investor Fairmount as repeatedly executing these complicated deals and helping improve the reputation of reverse mergers.